Ebola Patient Who Received Aethlon Hemopurifier® Therapy Has Been Discharged From Hospital
Print
Alert
Aethlon Medical, Inc. (USOTC:AEMD)
Intraday Stock Chart
Today : Tuesday 25 November 2014
Click Here for more Aethlon Medical, Inc. Charts.
SAN DIEGO, Nov. 25, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, disclosed today that an Ebola patient who received Hemopurifier® therapy has been reported to have been discharged from Frankfurt University Hospital in Germany. The patient was a Ugandan physician, who became infected with Ebola in Sierra Leone where he was treating other Ebola patients.